Methocel 50 mg Injection 1's belongs to the class of medicines called 'anti-metabolites and immunosuppressants' used to treat active rheumatoid arthritis, including polyarticular juvenile rheumatoid arthritis and severe psoriasis. Methocel 50 mg Injection 1's is also used to treat cancer such as breast cancer, cervical cancer, bladder cancer, ovarian cancer, testicular cancer, lung cancer, head and neck cancer, mycosis fungoides (type of blood cancer), bone cancer, and advanced stage non-Hodgkin's lymphomas (cancer that starts in the lymphatic system).

Methocel 50 mg Injection 1's contains 'Methotrexate' that works by interrupting the processes of the immune system that cause inflammation in the joint tissues. It reduces pain and inflammation and delays joint damage and disease progression over time. Besides this, Methocel 50 mg Injection 1's prevents and stops the growth of cancer cells, thereby helps treat cancer. Methocel 50 mg Injection 1's treats psoriasis by suppressing the overactive immune system that is responsible for causing psoriasis.

Methocel 50 mg Injection 1's will be administered by a qualified healthcare professional; do not self-administer. In some cases, Methocel 50 mg Injection 1's may cause side-effects such as nausea, vomiting, diarrhoea, unusual fatigue, dizziness, headache, loss of appetite, lowered resistance to infections, tingling sensation, leukopenia (decreased number of white blood cells), and soreness of mouth and lips. You are advised to talk to your doctor if you experience any of the side effects persistently.

Do not take Methocel 50 mg Injection 1's if you are pregnant or breastfeeding. Methocel 50 mg Injection 1's may cause dizziness and fatigue, so avoid driving or operating machinery. Avoid consuming alcohol whilst on treatment with Methocel 50 mg Injection 1's. If you are due to undergo any surgery, including dental surgery, inform the doctor that you are receiving Methocel 50 mg Injection 1's. Do not have any vaccinations during treatment with Methocel 50 mg Injection 1's without consulting your doctor. Inform your doctor about your medications and health condition to rule out any unpleasant side effects.

Methocel 50 mg Injection 1's belongs to the class of medicines called 'anti-metabolites and immunosuppressants' used to treat active rheumatoid arthritis including polyarticular juvenile rheumatoid arthritis (arthritis in children) and severe psoriasis. Methocel 50 mg Injection 1's helps treat rheumatoid arthritis by interrupting the processes of the immune system that cause inflammation in the joint tissues. It reduces pain and inflammation and delays joint damage and disease progression over time. Methocel 50 mg Injection 1's treats psoriasis by suppressing the overactive immune system that is responsible for causing psoriasis. Methocel 50 mg Injection 1's is used to treat breast cancer, lung cancer, head and neck cancer, mycosis fungoides (type of blood cancer), and advanced stage non-Hodgkin's lymphomas (cancer that starts in the lymphatic system). Methocel 50 mg Injection 1's prevents and stops the growth of cancer cells by interfering with DNA production.

Do not take Methocel 50 mg Injection 1's if you are allergic to any of its contents; if you are pregnant or breastfeeding. Inform your doctor if you have immunodeficiency conditions, bone marrow problems, low white blood cell count, low platelet count, serious anaemia, liver problems due to alcohol abuse, liver, lung or kidney problems, ulceration in the stomach or bowels, poor general condition, received any vaccinations or if are due to have any, diabetes, ascites (fluid in the stomach area), lung problems or fluid in the lungs. Methocel 50 mg Injection 1's may cause a serious, life-threatening reaction. If you experience symptoms such as rash, itching, hives, throat tightness, trouble swallowing, swelling of the face, throat, lips, or tongue; runny or stuffy nose, lightheadedness or dizziness, chest pain, difficulty breathing, wheezing, or feeling faint, consult your doctor immediately. Inform your doctor if you are undergoing radiation therapy; if you receive Methocel 50 mg Injection 1's while you are being treated with radiation therapy for cancer, it may cause damage to the skin, bones, or other parts of the body.

• Women of child-bearing potential must use effective contraception whilst on treatment with Methocel 50 mg Injection 1's and for at least 6 months after the last dose.
• If you are a male, you and your partner should use reliable contraception during treatment with Methocel 50 mg Injection 1's and for at least 3 months after the last dose.
• Methocel 50 mg Injection 1's may make you more susceptible to infections; consult your doctor if you develop any signs of infections such as fever, sore throat, breathlessness, jaundice, unexplained bleeding or bruising.
• Your doctor may advise regular blood tests, kidney and liver tests to monitor your condition.